Model for End-Stage Liver Disease Score Predicts Adverse Events Related to Ventricular Assist Device Therapy
Authors:
- Pramod BondePBPramod Bonde
- Natalie C. KuNKNatalie C. Ku
- Elizabeth A. GenoveseEGElizabeth A. Genovese
- Christian A. BermudezCBChristian A. Bermudez
- Jay K. BhamaJBJay K. Bhama
- Maria M. CiarleglioMCMaria M. Ciarleglio
- Xiangyu CongXCXiangyu Cong
- Jeffrey J. TeutebergJTJeffrey J. Teuteberg
- Robert L. KormosRKRobert L. Kormos
- 1 May 2012
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 93 (5) , 1541-1548
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Early adverse events as predictors of 1-year mortality during mechanical circulatory supportThe Journal of Heart and Lung Transplantation, 2010
- Patient Selection for Left Ventricular Assist DevicesEuropean Journal of Heart Failure, 2010
- Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implantsThe Journal of Heart and Lung Transplantation, 2010
- Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2009
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DeviceJACC, 2009
- Patient selection for left-ventricular assist devicesCurrent Opinion in Cardiology, 2009
- Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH EraCirculation, 2007
- Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart FailureThe Journal of Heart and Lung Transplantation, 2006
- Ventricular assist device-related infectionsThe Lancet Infectious Diseases, 2006
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001